JARDIANCE (empagliflozin) tablets

JARDIANCE is a prescription medicine used to: lower blood sugar along with diet and exercise in adults with type 2 diabetes. reduce the risk of cardiovascular death in adults with type 2 diabetes who also have known cardiovascular disease. Brand Name:JARDIANCE (empagliflozin) tablets, for oral use Initial U.S. Approval: 2014

Home | (empagliflozin) tablets

JARDIANCE (empagliflozin) tablets India Delhi Ahmedabad Bengaluru Chennai Kolkata Mumbai
JARDIANCE (empagliflozin) tablets

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

JARDIANCE (empagliflozin) tablets

Empagliflozin, sold under the brand name Jardiance among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes.

JARDIANCE is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated:
– as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,
– to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.

Empagliflozin is indicated in adults with heart failure (both reduced and preserved ejection fraction) to reduce the risk of hospitalisation for heart failure and to a lesser extent, cardiovascular death; in adults with type 2 diabetes and established cardiovascular disease to reduce the risk of cardiovascular death; and as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and works by increasing sugar lost in the urine. Empagliflozin was approved for medical use in the United States and in the European Union in 2014. It is on the World Health Organization’s List of Essential Medicines. It has received approval as a generic medication from the US Food and Drug Administration (FDA).

Drug (Brand / Generic): JARDIANCE / empagliflozin
Current Indications: type 2 diabetes mellitus
Marketed by:: Boehringer Ingelheim Pharmaceuticals, Inc.
Approval Date: 2014

Dosage forms and strengths of JARDIANCE (empagliflozin).
Tablets: 10 mg, 25 mg

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “JARDIANCE (empagliflozin) tablet”.

Confirmation of the order for JARDIANCE (empagliflozin) tablets will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.

We have delivered medicines to following cities in India –  Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha

ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand JARDIANCE (empagliflozin) tablets. The import process requires a valid prescription and an Import License in the Patient’s Name.

For patients from following foreign countries seeking access to JARDIANCE (empagliflozin) tablets, they can inquire and find further information by sending their inquiries to ALS.

We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.

Kindly reach out to us for JARDIANCE (empagliflozin) tablets price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.